AcuCort AB (XSAT:ACUC) Total Receivables: kr1.68 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:ACUC AcuCort AB XSAT:ACUC
32 GF Score
Price kr0.64
! 2 Warning Signs
View Full Analysis

What is AcuCort AB Total Receivables?

AcuCort AB XSAT:ACUC 32 Total Receivables is kr1.68 Mil as of Mar. 2026. GuruFocus rates XSAT:ACUC with a GF Score™ of 32/100. The stock has 2 warning signs investors should review.

AcuCort AB's Total Receivables for the quarter that ended in Mar. 2026 was kr1.68 Mil.

AcuCort AB Total Receivables Historical Data

* Premium members only.

The historical data trend for AcuCort AB's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AcuCort AB Total Receivables Chart

AcuCort AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.93 0.97 1.10 0.97 0.79

AcuCort AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.65 2.00 0.94 0.79 1.68
XSAT:ACUC
32GF Score
AcuCort AB XSAT:ACUC
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AcuCort AB Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of kr1.68 Mil mean?
AcuCort AB (XSAT:ACUC) has a Total Receivables of kr1.68 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on AcuCort AB and its competitors.
Is AcuCort AB's Total Receivables too high?
AcuCort AB's current Total Receivables is kr1.68 Mil. Overall, AcuCort AB has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does AcuCort AB's Total Receivables compare to ZTS and UTHR?
AcuCort AB's Total Receivables of kr1.68 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on AcuCort AB and its competitors. AcuCort AB's current Total Receivables is kr1.68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AcuCort AB stock overvalued right now?
AcuCort AB (XSAT:ACUC) has a current Total Receivables of kr1.68 Mil. The current Total Receivables is kr1.68 Mil. AcuCort AB's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For AcuCort AB (XSAT:ACUC), the current Total Receivables is kr1.68 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AcuCort AB Business Description

Address Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
AcuCort AB is an innovative biotechnology company that identifies, develops and commercializes smart drugs that meet the patient's needs for a user-friendly and effective treatment.
32GF Score

Get the complete analysis for XSAT:ACUC

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.64
Price